Literature DB >> 8971091

Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetes.

T J Allen1, M J Waldron, D Casley, G Jerums, M E Cooper.   

Abstract

The effects of dietary salt restriction on the renin-angiotensin system, glomerular filtration rate (GFR), renal size, and albuminuria were assessed in streptozotocin diabetic rats. Two series of experiments were performed: one short-term with severe salt restriction and the second long-term with moderate salt restriction. The first studied the effect of a very-low-salt diet for 4 weeks on GFR, renal size, and plasma angiotensin II concentration in diabetic and control rats. Diabetic and control male Sprague-Dawley rats received either a very-low-salt (0.005% NaCl) or a normal-salt (0.4% NaCl) diet. Diabetes was associated with a 49% increase in GFR, a 34% increase in kidney weight, and an 85% reduction in plasma angiotensin II when compared with control rats (P < 0.001). Sodium restriction in diabetic rats reduced GFR, restored plasma angiotensin II to control values, and retarded kidney growth when compared with diabetic rats receiving a normal sodium diet. GFR correlated negatively with plasma angiotensin II (r = -0.65, P < 0.001) and positively with kidney weight (r = 0.66, P < 0.001). In the second experiment, serial measurements of albuminuria and GFR were performed in control, diabetic, and salt-restricted (0.05% NaCl) control and diabetic rats over 24 weeks. Albuminuria showed a continuous rise in the diabetic rats when compared with control rats. Salt restriction attenuated the increase in albuminuria over the whole study period as well as reducing blood pressure and kidney weight in the diabetic rats. In conclusion, sodium restriction was associated with a lower GFR and kidney weight after 4 weeks and reduced levels of albuminuria, kidney weight, and blood pressure after 24 weeks in diabetic rats. Salt restriction may have an important role in the prevention and treatment of diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8971091     DOI: 10.2337/diabetes.46.1.19

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  12 in total

1.  Non-pressure-related effects of dietary sodium.

Authors:  Guilhem du Cailar; Albert Mimran
Journal:  Curr Hypertens Rep       Date:  2009-02       Impact factor: 5.369

Review 2.  The RAAS in the pathogenesis and treatment of diabetic nephropathy.

Authors:  Piero Ruggenenti; Paolo Cravedi; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2010-05-04       Impact factor: 28.314

3.  Sodium intake, ACE inhibition, and progression to ESRD.

Authors:  Stefan Vegter; Annalisa Perna; Maarten J Postma; Gerjan Navis; Giuseppe Remuzzi; Piero Ruggenenti
Journal:  J Am Soc Nephrol       Date:  2011-12-01       Impact factor: 10.121

4.  Effects of intensive low-salt diet education on albuminuria among nondiabetic patients with hypertension treated with olmesartan: a single-blinded randomized, controlled trial.

Authors:  Jin Ho Hwang; Ho Jun Chin; Sejoong Kim; Dong Ki Kim; Suhnggwon Kim; Jung Hwan Park; Sung Joon Shin; Sang Ho Lee; Bum Soon Choi; Chun Soo Lim
Journal:  Clin J Am Soc Nephrol       Date:  2014-10-20       Impact factor: 8.237

Review 5.  The salt paradox and its possible implications in managing hypertensive diabetic patients.

Authors:  Volker Vallon; Roland Blantz; Scott Thomson
Journal:  Curr Hypertens Rep       Date:  2005-04       Impact factor: 5.369

6.  Effects of aggressive approach to the multiple risk factors for diabetic nephro-pathy on proteinuria reduction in diabetes type 2 patients.

Authors:  Belma Ascić-Buturović; Mirsad Kacila; Mehmed Kulić
Journal:  Bosn J Basic Med Sci       Date:  2009-02       Impact factor: 3.363

Review 7.  Optimizing target-organ protection in patients with diabetes mellitus: angiotensin-converting enzyme inhibitors or angiotensin receptor blockers?

Authors:  Wei X Lu; Jay Lakkis; Matthew R Weir
Journal:  Curr Hypertens Rep       Date:  2003-06       Impact factor: 5.369

Review 8.  Pathophysiology of the diabetic kidney.

Authors:  Volker Vallon; Radko Komers
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

9.  Interaction between NO synthase and NADPH oxidase in control of sodium transport by the renal thick ascending limb during diabetes.

Authors:  C De Miguel; J M Foster; P K Carmines; J S Pollock
Journal:  Acta Physiol (Oxf)       Date:  2013-07-25       Impact factor: 6.311

Review 10.  Non-pressure-related effects of dietary sodium.

Authors:  Guilhem du Cailar; Albert Mimran
Journal:  Curr Hypertens Rep       Date:  2007-04       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.